Joint Attention-Based AI System Helps Detect Autism

2023-05-31
临床结果
WEDNESDAY, May 31, 2023 -- A joint attention-based deep learning system provides good predictive performance for differentiating autism spectrum disorder (ASD) from typical development (TD), according to a study published online May 25 in JAMA Network Open.
Chanyoung Ko, M.D., from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues trained deep learning models to distinguish ASD from TD and to differentiate ASD symptom severities. Joint attention tasks were administered to children with and without ASD, and video data were obtained from multiple institutions. Ninety-five of 110 children completed study measures. The analytical population included 45 children with ASD and 50 with TD.
The researchers observed good predictive performance for the deep learning ASD versus TD model for initiation of joint attention (IJA; area under the receiver operating characteristic curve [AUROC], 99.6 percent; accuracy, 97.6 percent; precision, 95.5 percent; and recall, 99.2 percent); low-level response to joint attention (RJA; AUROC, 99.8 percent; accuracy, 98.8 percent; precision, 98.9 percent; and recall, 99.1 percent); and high-level RJA (AUROC, 99.5 percent; accuracy, 98.4 percent; precision, 98.8 percent; and recall, 98.6 percent). Reasonable predictive performance was seen for IJA, low-level RJA, and high-level RJA in the deep learning-based ASD symptom severity models.
"We believe our research opens possibilities for gathering large data sets on behavioral biomarkers through standardized video data acquisition setup amenable to computer vision and deep learning and applicable to a wide range of neuropsychiatric conditions," the authors write.
Two authors disclosed ties to LumanLab, and three disclosed having patents for the method and apparatus for diagnosis of developmental disability severity in toddlers based on joint attention.
Abstract/Full Text
Posted May 2023
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。